- Home
- ZNTL vs ACB Comparison
ZNTL vs ACB Comparison
Compare ZNTL & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- ACB
- Stock Information
- Founded
- ZNTL 2014
- ACB 2013
- Country
- ZNTL United States
- ACB Canada
- Employees
- ZNTL N/A
- ACB N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- ZNTL Health Care
- ACB Health Care
- Exchange
- ZNTL Nasdaq
- ACB Nasdaq
- Market Cap
- ZNTL 105.8M
- ACB 256.5M
- IPO Year
- ZNTL 2020
- ACB N/A
- Fundamental
- Price
- ZNTL $1.49
- ACB $5.18
- Analyst Decision
- ZNTL Buy
- ACB
- Analyst Count
- ZNTL 6
- ACB 0
- Target Price
- ZNTL $6.53
- ACB N/A
- AVG Volume (30 Days)
- ZNTL 740.6K
- ACB 1.1M
- Earning Date
- ZNTL 11-11-2025
- ACB 11-05-2025
- Dividend Yield
- ZNTL N/A
- ACB N/A
- EPS Growth
- ZNTL N/A
- ACB N/A
- EPS
- ZNTL N/A
- ACB N/A
- Revenue
- ZNTL $26,865,000.00
- ACB $262,403,032.00
- Revenue This Year
- ZNTL N/A
- ACB $9.42
- Revenue Next Year
- ZNTL N/A
- ACB $3.01
- P/E Ratio
- ZNTL N/A
- ACB N/A
- Revenue Growth
- ZNTL N/A
- ACB 28.58
- 52 Week Low
- ZNTL $1.01
- ACB $3.42
- 52 Week High
- ZNTL $4.46
- ACB $6.91
- Technical
- Relative Strength Index (RSI)
- ZNTL 44.97
- ACB 55.72
- Support Level
- ZNTL $1.40
- ACB $4.87
- Resistance Level
- ZNTL $2.02
- ACB $5.11
- Average True Range (ATR)
- ZNTL 0.11
- ACB 0.20
- MACD
- ZNTL -0.04
- ACB -0.01
- Stochastic Oscillator
- ZNTL 21.43
- ACB 53.09
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.